ArticleBMC nursing2025
Person-centred care during treatment with nasal esketamine - a qualitative study.
Article in BMC nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating Psychiatric, Psychotherapeutic, and Nursing Care in Intranasal Esketamine for Treatment-Resistant Depression.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients suffering from treatment-resistant depression may be treated with nasal esketamine. The treatment requires administration in a healthcare facility and monitoring by a nurse. Existing research has mainly focused on the clinical effect of nasal esketamine, while less is known about patients' experiences of treatment. A person-centred framework provides valuable insights into care and treatment. By using person-centredeness, the patient turns into a respected contributor in the delivery of care, enabling improved outcomes, better use of resources, reduced costs and increased satisfaction with care. Thus, the aim was to explore patients' experiences of treatment with nasal esketamine utilizing the person-centred nursing framework by McCormack and McCance.
methodsThe study had a qualitative design with an abductive approach. Twenty patients with treatment-resistant depression who had received at least eight treatments of nasal esketamine were interviewed. A thematic analysis was conducted, based on the four constructs of PCC: prerequisites, care environment, person-centred process and expected outcomes. The analysis generated 11 subthemes, reflecting the contextuality of the PCC nursing framework.
resultsThe results highlighted the importance of working in a person-centred manner to achieve increased patient satisfaction and treatment outcomes. Patients highlighted the importance of relationships with competent and engaged nurses and a supportive care environment for treatment outcomes. The physical care environment influenced patients' well-being, and organizational aspects, such as continuity of staff, flexibility, and being allowed a private space, were also crucial during esketamine treatment. These aspects fostered feelings of security and contributed to achieving the desired outcome.
conclusionThis study identified that key aspects of PCC; competent nurses and respect for the patient, comfort and personalization of the care environment, support and involvement are important in ensuring patient satisfaction, quality and ultimately the desired treatment outcomes in esketamine treatment. By adopting a person-centred approach, nurses can increase patient well-being and the quality of care in nasal esketamine treatment. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.